Reham Ali
Assistant Professor
The University of Texas MD Anderson Cancer Center at Houston
Department of Melanoma Medical Oncology
I am an oncologist with a Ph.D. in Clinical Research, serving as an Assistant Professor at the Melanoma
Medical Oncology Department, MD Anderson Cancer Center, and I have an adjunct Tenure Associate
Professor Faculty position at the Clinical Oncology Department at Assiut University in Egypt.
With over 15 years of work experience, I led and collaborated on multiple projects to explore the interplay
of tumor biology and immunology; thus I have been focusing on establishing a centralized clinically
annotated biorepository for various cancers to study debatable disease risk factors, evaluating various
-term outcomes using real-world data, and discover predictive and prognostic biomarkers for treatment response, resistance, and toxicities aiming to improve patient outcomes and enhance the understanding of the immune response in cancer. Melanoma is a unique immune-sensitive cancer with diverse immune agents used in the standard of care; it provides a tremendous opportunity to study the immune biology of the tumor microenvironment compared with other
immunologically cold tumors, the inflamed/autoimmune tissues and identifies biomarkers of response,
resistance, and toxicities.
So far, my research productivity has led to several peer-reviewed publications, and I successfully secured
several research federal and non-federal funding supports. Moreover, I am the recipient of several
prestigious awards and recognitions, including the ASCO Conquer Cancer Foundation Global Oncology
Young Investigator Award, the MD Anderson Marion D. Edwards Fellowship Award in Hepatic Oncology,
the ESTRO Technology Transfer Award, and the Leadership Award from the Memorial Sloan Kettering
Cancer Center/the American University of Beirut.
Education & Training
PhD, Assiut University, 2015
MD, Assiut University, 2005